|
Antidepressants
effectiveness
pediatric:
The
number
of
studies
of
children
12
years
of
age
and
under
is
very
limited.
The
following
studies
are
submitted
on
this
site
for
review.
study
#2
below
reveals
the
best
results
seen
in
literature
review,
still
76.4%
of
subjects
in
the
study
achieve
relief
of
symptoms
not
better
than
placebo.
Full text
pediatric study
1
study
1: Double blind placebo controlled 10 week
depression study
of serotonin depression reuptake inhibitor Zoloft (sertraline) versus placebo 6 to 11
years old for the treatment of depression, n = 177.
Conclusion: "There were no statistically
significant depression differences in time to first response or
first persistent response between serotonin depression reuptake
inhibitor sertraline and
placebo in depression children.."
Full text
pediatric study
2
study 2: Literature
review, treatment of depression with serotonin
depression reuptake
inhibitor Prozac
(fluoxetine) versus placebo in children with
depression less than 12
years old, N = 134. Conclusion: "Within
depression children, response at exit to serotonin
depression reuptake
inhibitor fluoxetine was
significantly better than placebo (56.9% vs 33.3%;
P=.009)" 76.4% of pediatric people suffering
with depression treated for
depression with serotonin depression reuptake inhibitor Prozac can expect outcomes no better
than placebo based on this depression study. |
